200 related articles for article (PubMed ID: 33394095)
1. Evaluation of cytokines in the tumor microenvironment of lung cancer using bronchoalveolar lavage fluid analysis.
Bezel P; Valaperti A; Steiner U; Scholtze D; Wieser S; Vonow-Eisenring M; Widmer A; Kowalski B; Kohler M; Franzen DP
Cancer Immunol Immunother; 2021 Jul; 70(7):1867-1876. PubMed ID: 33394095
[TBL] [Abstract][Full Text] [Related]
2. Analysis of cytokines in serum and bronchoalveolar lavage fluid in patients with immune-checkpoint inhibitor-associated pneumonitis: a cross-sectional case-control study.
Kowalski B; Valaperti A; Bezel P; Steiner UC; Scholtze D; Wieser S; Vonow-Eisenring M; Widmer A; Kohler M; Franzen D
J Cancer Res Clin Oncol; 2022 Jul; 148(7):1711-1720. PubMed ID: 34347128
[TBL] [Abstract][Full Text] [Related]
3. Clinical importance of bronchoalveolar lavage fluid and blood cytokines, surfactant protein D, and Kerbs von Lungren 6 antigen in idiopathic pulmonary alveolar proteinosis.
Lin FC; Chen YC; Chang SC
Mayo Clin Proc; 2008 Dec; 83(12):1344-9. PubMed ID: 19046553
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of cytokine levels (TNF-alpha, IL-2 and IFN-gamma) in bronchoalveolar lavage fluid of smear-negative pulmonary tuberculosis patients.
Küpeli E; Karnak D; Beder S; Kayacan O; Tutkak H
Respiration; 2008; 75(1):73-8. PubMed ID: 17975298
[TBL] [Abstract][Full Text] [Related]
5. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases.
Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Skibova J; Striz I
Scand J Immunol; 2009 Mar; 69(3):268-74. PubMed ID: 19281539
[TBL] [Abstract][Full Text] [Related]
6. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.
Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A
Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659
[TBL] [Abstract][Full Text] [Related]
7. Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients.
Schmidt K; Martinez-Gamboa L; Meier S; Witt C; Meisel C; Hanitsch LG; Becker MO; Huscher D; Burmester GR; Riemekasten G
Arthritis Res Ther; 2009; 11(4):R111. PubMed ID: 19615053
[TBL] [Abstract][Full Text] [Related]
8. Novel cytokines: IL-27, IL-29, IL-31 and IL-33. Can they be useful in clinical practice at the time diagnosis of lung cancer?
Naumnik W; Naumnik B; Niewiarowska K; Ossolinska M; Chyczewska E
Exp Oncol; 2012 Dec; 34(4):348-53. PubMed ID: 23302994
[TBL] [Abstract][Full Text] [Related]
9. Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation.
Ohkawara Y; Lei XF; Stämpfli MR; Marshall JS; Xing Z; Jordana M
Am J Respir Cell Mol Biol; 1997 May; 16(5):510-20. PubMed ID: 9160833
[TBL] [Abstract][Full Text] [Related]
10. Heparin-binding protein, lysozyme, and inflammatory cytokines in bronchoalveolar lavage fluid as diagnostic tools for pulmonary infection in lung transplanted patients.
Stjärne Aspelund A; Hammarström H; Inghammar M; Larsson H; Hansson L; Christensson B; Påhlman LI
Am J Transplant; 2018 Feb; 18(2):444-452. PubMed ID: 28787761
[TBL] [Abstract][Full Text] [Related]
11. Serum and Bronchoalveolar Lavage Fluid Levels of Cytokines in Patients with Lung Cancer and Chronic Lung Disease: A Prospective Comparative Study.
Hogea P; Tudorache E; Fira-Mladinescu O; Marc M; Velescu D; Manolescu D; Bratosin F; Rosca O; Mavrea A; Oancea C
J Pers Med; 2023 Jun; 13(6):. PubMed ID: 37373987
[TBL] [Abstract][Full Text] [Related]
12. Variability of cytokine concentration in whole blood serum and bronchoalveolar lavage over time.
Valaperti A; Bezel P; Vonow-Eisenring M; Franzen D; Steiner UC
Cytokine; 2019 Nov; 123():154768. PubMed ID: 31276936
[TBL] [Abstract][Full Text] [Related]
13. Bronchoalveolar lavage fluid alteration in antioxidant and inflammatory status in lung cancer patients.
Kontakiotis T; Katsoulis K; Hagizisi O; Kougioulis M; Gerou S; Papakosta D
Eur J Intern Med; 2011 Oct; 22(5):522-6. PubMed ID: 21925065
[TBL] [Abstract][Full Text] [Related]
14. Th1 cytokine pattern (IL-12 and IL-18) in bronchoalveolar lavage fluid (BALF) before and after treatment with interferon gamma-1b (IFN-gamma-1b) or colchicine in patients with idiopathic pulmonary fibrosis (IPF/UIP).
Antoniou KM; Alexandrakis MG; Sfiridaki K; Tsiligianni I; Perisinakis K; Tzortzaki EG; Siafakas NM; Bouros DE
Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):105-10. PubMed ID: 15281431
[TBL] [Abstract][Full Text] [Related]
15. Intracellular detection of interleukin 17 and other cytokines in human bronchoalveolar lavage fluid: a first assessment.
De Luca A; Rindi L; Celi A; Melosini L; Paggiaro P; Nelli LC; Garzelli C; Freer G
Immunol Lett; 2012 Jan; 141(2):204-9. PubMed ID: 22020264
[TBL] [Abstract][Full Text] [Related]
16. Blood cell redistribution in the lung after administration of recombinant human granulocyte-macrophage colony-stimulating factor.
Gatti E; Scagliotti GV; Ferrari G; Mutti L; Pozzi E; Stacchini A; Fubini L; Aglietta M
Eur Respir J; 1995 Sep; 8(9):1566-71. PubMed ID: 8575586
[TBL] [Abstract][Full Text] [Related]
17. Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma.
Wislez M; Fleury-Feith J; Rabbe N; Moreau J; Cesari D; Milleron B; Mayaud C; Antoine M; Soler P; Cadranel J
Am J Pathol; 2001 Oct; 159(4):1423-33. PubMed ID: 11583970
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 5 and granulocyte-macrophage colony-stimulating factor levels in bronchoalveolar lavage fluid in interstitial lung disease.
Taniguchi H; Katoh S; Kadota J; Matsubara Y; Fukushima K; Mukae H; Matsukura S; Kohno S
Eur Respir J; 2000 Nov; 16(5):959-64. PubMed ID: 11153599
[TBL] [Abstract][Full Text] [Related]
19. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
20. Bronchoalveolar lavage fluid reveals factors contributing to the efficacy of PD-1 blockade in lung cancer.
Masuhiro K; Tamiya M; Fujimoto K; Koyama S; Naito Y; Osa A; Hirai T; Suzuki H; Okamoto N; Shiroyama T; Nishino K; Adachi Y; Nii T; Kinugasa-Katayama Y; Kajihara A; Morita T; Imoto S; Uematsu S; Irie T; Okuzaki D; Aoshi T; Takeda Y; Kumagai T; Hirashima T; Kumanogoh A
JCI Insight; 2022 May; 7(9):. PubMed ID: 35389889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
